A new comprehensive analysis of thyroid cancer from The Cancer Genome Atlas Research Network has identified markers of aggressive tumors, which could allow for better targeting of appropriate treatments to individual patients.
Right out of the starting gate, Michigan’s expansion of health coverage for the poor and near-poor holds lessons for other states that are still on the fence about expanding their own Medicaid programs under the Affordable Care Act, a new analysis shows.
Scientists have restored the hearing of mice partly deafened by noise, using advanced tools to boost the production of a key protein in their ears. By demonstrating the importance of the protein, called NT3, in maintaining communication between the ears and brain, these new findings pave the way for research in humans that could improve treatment of hearing loss caused by noise exposure and normal aging.
University of Michigan experts in genetic and statistical analysis, Lou Gehrig's Disease (ALS), head and neck cancer, health policy and nursing are among the new members of the Institute of Medicine of the National Academies, one of the highest honors in the fields of health and medicine.
A decade ago, America’s health care community took on heart attacks with gusto, harnessing the power of research and data to make sure that
every patient got the best possible care. It worked: death rates have dropped. Now, say a pair of U-M experts, it’s time to do the same for sepsis.
Deep in the brains of the million Americans with Parkinson’s disease, changes to their brain cells put them at high risk of dangerous falls -- a problem that resists even the most modern treatments. Now, U-M scientists and doctors have launched a five-year, $11.5 million effort to better understand the cause of these problems, and find new options based in the latest brain science.
Researchers at the U-M School of Public Health and Medical School and collaborators at two other institutions will undertake the largest whole genome sequencing study funded to date, as they seek to better understand bipolar disorder and schizophrenia.
Every day, organ transplant patients around the world take a drug called rapamycin to keep their immune systems from rejecting their new kidneys and hearts. New U-M research suggests that the same drug could help brain tumor patients by boosting the effect of new immune-based therapies.
A new study pulls back the curtain on one of the most contentious issues in health care: differences in payment between physicians who perform operations and those who don’t. Contrary to perception, the research indicates, the physician payment system is not inherently “rigged” to favor surgeons.
Two years ago, more than 1,800 doctors from U-M and around Michigan joined together to improve the care of 80,000 people who rely on Medicare, while also slowing the growth of their health costs. Data released yesterday show they achieved much of their aim in just the first year, though more opportunities remain to improve care and contain costs further.
A peek inside the brains of more than 750 children and teens reveals a key difference in brain architecture between those with attention deficit hyperactivity disorder and those without. Those with ADHD, U-M research finds, lag behind others of the same age in how quickly their brains form connections within, and between, key brain networks.
Doctors nationwide rate the U-M Health System as one of the best places for young doctors to train in their chosen field, across 20 medical specialties, according to a new ranking. Nearly 1,200 residents and fellows are currently training at University of Michigan in 105 specialties.
Doctors at one hospital may be as much as six times as likely to admit an emergency patient with a common non-life-threatening diagnosis to the hospital, compared with doctors at another hospital treating an identical patient, a new U-M study finds.
Dangerous brain tumors hijack the brain’s existing blood supply throughout their progression, by growing only within narrow potential spaces between and along the brain’s thousands of small blood vessels, new research shows for the first time. The findings contradict the concept that brain tumors grow their own blood vessels, and may lead to better treatments.
A depression treatment based on magnetic fields, not medications, appears to help many patients who don’t respond to other options. But no one really knows what it does to the brain – or why it works for some people. Now, a U-M team will try to find out, with a new study that’s now open for certain depressed people to join.